- Home
- MGX
MGX
METAGENOMI INC
as 03-28-2025 4:00pm EST
Stocks
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | EMERYVILLE |
| Market Cap: | N/A | IPO Year: | 2024 |
| Target Price: | $14.40 | AVG Volume (30 days): | 396.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.46 - $10.94 | Next Earning Date: | 03-17-2025 |
| Revenue: | $52,295,000 | Revenue Growth: | 16.84% |
| Revenue Growth (this year): | -34.12% | Revenue Growth (next year): | 17.98% |
Stock Insider Trading Activity of METAGENOMI INC (MGX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Wein Matthew | MGX | See Remarks | Mar 5 '25 | Sell | $1.87 | 930 | $1,743.56 | 9,467 | |
| Wapnick Pamela | MGX | Chief Financial Officer | Mar 5 '25 | Sell | $1.87 | 1,808 | $3,389.64 | 59,684 |
Latest METAGENOMI INC News
MGX Breaking Stock News: Dive into MGX Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
Bullish: Analysts Just Made A Significant Upgrade To Their Metagenomi, Inc. (NASDAQ:MGX) Forecasts
MT Newswires
13 days ago
Chardan Adjusts Price Target on Metagenomi to $13 From $15, Keeps Buy Rating
GlobeNewswire
14 days ago
Metagenomi Reports Business Updates and Full Year 2024 Financial Results
GlobeNewswire
18 days ago
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems
Simply Wall St.
a month ago
Alto Ingredients And 2 Other US Penny Stocks To Watch
GlobeNewswire
2 months ago
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference
GlobeNewswire
2 months ago
Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer
Quartz
2 months ago
People are buying the wrong stock thinking it's part of OpenAI's Stargate Project
Compare MGX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MGX METAGENOMI INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.